U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H16O6.C17H18Br2N4O2
Molecular Weight 858.528
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIBROMPROPAMIDINE EMBONATE

SMILES

NC(=N)C1=CC(Br)=C(OCCCOC2=C(Br)C=C(C=C2)C(N)=N)C=C1.OC(=O)C3=CC4=CC=CC=C4C(CC5=C(O)C(=CC6=CC=CC=C56)C(O)=O)=C3O

InChI

InChIKey=HFEFFNLWQCXXFD-UHFFFAOYSA-N
InChI=1S/C23H16O6.C17H18Br2N4O2/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;18-12-8-10(16(20)21)2-4-14(12)24-6-1-7-25-15-5-3-11(17(22)23)9-13(15)19/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2-5,8-9H,1,6-7H2,(H3,20,21)(H3,22,23)

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including http://www.goldeneyecare.co.uk/assets/Uploads/D52491-TP-GEOPL-UK-14v4-GoldenEye-Ointment-0.15.pdf | https://www.medicines.org.uk/emc/PIL.16474.latest.pdf

Dibrompropamidine isetionate is an antiseptic. Ointment containing dibrompropamidine isetionate is used to treat minor eye or eyelid infections, such as conjunctivitis and blepharitis.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
BROLENE

Approved Use

Dibrompropamidine isetionate is used for minor infections of the eye or eyelid.
PubMed

PubMed

TitleDatePubMed
Studies on the mode of action of dibromopropamidine.
1973 Jun-Aug
In vitro effect of diamidines on intracellular polyamines of Acanthamoeba polyphaga.
2001
Good visual outcome after prompt treatment of acanthamoeba keratitis associated with overnight orthokeratology lens wear.
2007 Nov
Acanthamoeba keratitis: 2007: a train wreck in slow motion.
2007 Sep
[When the treatment is the problem].
2009 Feb 12
[Graze with unusual progress].
2009 Feb 12
Cosmetic contact lens-related Acanthamoeba keratitis.
2009 May

Sample Use Guides

Eye ointment containing dibrompropamidine isethionate 0.15% w/w to the affected eye once or twice each day for at least 2 days
Route of Administration: Topical
In Vitro Use Guide
Dibrompropamidine isethionate, 300 μg/ml in aqueous solution was rapidly bactericidal, killing 99.9% of E. coli 15 TAU cells in 3 min.
Name Type Language
DIBROMPROPAMIDINE EMBONATE
Common Name English
BENZENECARBOXIMIDAMIDE, 4,4'-(1,3-PROPANEDIYLBIS(OXY))BIS(3-BROMO-, 4,4'-METHYLENEBIS(3-HYDROXY-2-NAPHTHALENECARBOXYLATE) (1:1)
Systematic Name English
EINECS 298-927-0
Code English
2-NAPHTHALENECARBOXYLIC ACID, 4,4'-METHYLENEBIS(3-HYDROXY-, COMPD. WITH 4,4'-(1,3-PROPANEDIYLBIS(OXY))BIS(3-BROMOBENZENECARBOXIMIDAMIDE) (1:1)
Systematic Name English
Dibrompropamidine embonate [WHO-DD]
Common Name English
Code System Code Type Description
CAS
93840-61-0
Created by admin on Sat Dec 16 13:44:07 GMT 2023 , Edited by admin on Sat Dec 16 13:44:07 GMT 2023
PRIMARY
EPA CompTox
DTXSID70917595
Created by admin on Sat Dec 16 13:44:07 GMT 2023 , Edited by admin on Sat Dec 16 13:44:07 GMT 2023
PRIMARY
PUBCHEM
56843770
Created by admin on Sat Dec 16 13:44:07 GMT 2023 , Edited by admin on Sat Dec 16 13:44:07 GMT 2023
PRIMARY
FDA UNII
1XH50DNH45
Created by admin on Sat Dec 16 13:44:07 GMT 2023 , Edited by admin on Sat Dec 16 13:44:07 GMT 2023
PRIMARY